Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.

Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, ...

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...

DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to ...

FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

ALR Technologies SG Ltd ('ALRT' or the 'Company') (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ('LOI') to acquire 100% equity of CGM Medical ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

New research from Montefiore Einstein investigators reveals that an underutilized tool, more commonly employed by ...

Ultrahuman has launched the new M2 Live glucose monitoring platform, which doesn't require a subscription and is cheaper than the M1 Live.

(MENAFN- EIN Presswire) EINPresswire/ -- As diabetes technology becomes part of daily care for more people, Medtrum is highlighting a practical design question: when devices are used day after day, ...